k CAR T cell immunotherapy, illustration Illustration of CAR chimeric antigen receptor T cell immunotherapy, a process that is being developed to treat cancer. T cells one at centre, part of the bodys immune system, are taken from the patient and have their DNA deoxyribonucleic acid modified by viruses spiky spheres so that they produce chimeric antigen receptor CAR proteins. These proteins will be specific to the patients cancer. The modified T cells are then multiplied in the laboratory before being reintroduced to the patient., by KEITH CHAMBERSSCIENCE PHOTO LIBRARY Stock Photo - Afloimages
Sign up
Login
All images
CAR T cell immunotherapy, illustration Illustration of CAR  chimeric antigen receptor  T cell immunotherapy, a process that is being developed to treat cancer. T cells  one at centre , part of the body s immune system, are taken from the patient and have their DNA  deoxyribonucleic acid  modified by viruses  spiky spheres  so that they produce chimeric antigen receptor  CAR  proteins. These proteins will be specific to the patient s cancer. The modified T cells are then multiplied in the laboratory before being reintroduced to the patient., by KEITH CHAMBERS SCIENCE PHOTO LIBRARY
RM

CAR T cell immunotherapy, illustration

Illustration of CAR (chimeric antigen receptor) T cell immunotherapy, a process that is being developed to treat cancer. T cells (one at centre), part of the body's immune system, are taken from the patient and have their DNA (deoxyribonucleic acid) modified by viruses (spiky spheres) so that they produce chimeric antigen receptor (CAR) proteins. These proteins will be specific to the patient's cancer. The modified T cells are then multiplied in the laboratory before being reintroduced to the patient., by KEITH CHAMBERS/SCIENCE PHOTO LIBRARY

Details

ID
160236511

Collection

License type
Rights Managed

Photographer



Sign in
Member access
Login not found.